William Tanner


Supernus Pharmaceuticals Inc (SUPN) Investors Are Scared Off by Elimination of Low SPN-810 Dose; Cantor Makes a Bullish Case

Supernus investors are running for the hills, but analyst sees elimination of 18 mg dose as a good move.

Cantor Offers Bullish Forecast on Synergy Pharmaceuticals Inc (SGYP) Following 2Q Earnings Showcase

Investors to get a better viewpoint of Trulance during today’s call, says analyst.

Cantor Shines Light on TherapeuticsMD Inc (TXMD) Following Publication of Clinical Data in Menopause

Cantor analyst William Tanner is out today with a few insights on TherapeuticsMD Inc (NYSEMKT:TXMD), after the drug maker announced the publication of a manuscript …

TherapeuticsMD Inc (TXMD) VVA Drug Could Be Approved by Early 2018: Cantor

Largely dismissing investor skepticism questioning the viability of TherapeuticsMD Inc (NYSEMKT:TXMD) vaginal soft gel capsule TX-004, analyst William Tanner of Cantor is confident …

Most Important Part of Novavax, Inc. (NVAX) 2Q Update May Point to NanoFlu, Wagers Cantor

Novavax, Inc. (NASDAQ:NVAX) shares were rising 5% in after-hours trading yesterday after the company reported second-quarter financials and provided investors with an update …

Cantor Remains Bullish on TherapeuticsMD Inc (TXMD) as Investors Await Clarity on TX-004

Cantor analyst William Tanner is out with a research note on shares of TherapeuticsMD Inc (NYSEMKT:TXMD), after the company provided an update regarding the New Drug Application …

This Analyst Sees 200% Upside for Synergy Pharmaceuticals Inc (SGYP)

In a research report released Thursday, Cantor analyst William Tanner initiated coverage on shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP) with an Overweight rating and price target …

Cantor Looks Beyond Novavax, Inc. (NVAX) Pullback to Big Milestones in 2H17

Novavax, Inc. (NASDAQ:NVAX) shares fell almost 10% in after-market hours on the heels of the firm’s release of fourth-quarter financials and clinical updates.

Cantor Cheers As Jazz Pharmaceuticals plc Shares Rise 9%

Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) stock is on a 9% rise after receiving abbreviated new drug application (ANDA) approval as well …

AMAG Pharmaceuticals, Inc. (AMAG): Makena Autoinjector Key to Stock Performance in 2017

Cantor analyst William Tanner remains sidelined on shares of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) amid their nearly 36% crash yesterday.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts